Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Methods × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 7 Lung Neoplasms 5 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Prostatic Neoplasms 3 Papillomavirus Infections 3 Neoplasms 3 Neoplasm Metastasis 3 Lymphoma 3 Smoking Cessation 2 Skin Carcinoma 2 Pain 2 Obesity-Related Malignant Neoplasm 2 Hematologic Neoplasms 2 Breast Carcinoma In Situ 2 Anatomic Stage I Breast Cancer AJCC v8 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tobacco Smoking 1 Smoking 1 Sepsis 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Cancer Liver Metastases 1 Ovarian Neoplasms 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1

Interventions

Gemcitabine 24 pembrolizumab 18 Cisplatin 17 Specimen Handling 14 Magnetic Resonance Spectroscopy 14 durvalumab 11 enfortumab vedotin 9 Nivolumab 9 avelumab 8 atezolizumab 7 Cystectomy 7 Mitomycin 6 Cystoscopy 6 Carboplatin 6 Radiation 5 Docetaxel 5 Biopsy 5 Transurethral Resection of Bladder 4 Standard of Care 4 Radiotherapy 4 Paclitaxel 4 Ipilimumab 4 Fluorouracil 4 sacituzumab govitecan 3 erdafitinib 3 dehydroftorafur 3 cabozantinib 3 Practice Guidelines as Topic 3 Platinum 3 Mitozytrex 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05679557 2026-02-27

COMPETENCE

Aarhus University Hospital

Phase NA Recruiting

Frailty, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡